In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Bellerophon Therapeutics, Inc.. Trade Record

NASDAQ:BLPH Bellerophon Therapeutics, Inc. stock gains 108.61% Exit Mar 14, 2017 a Trade Record by priceseries

Trade Chart
Trade Chart BLPH Feb 10, 2017, priceSeries
About Bellerophon Therapeutics, Inc.

Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products at the intersection of drugs and devices that address unmet medical needs in the treatment of cardiopulmonary diseases. Its product candidates is INOpulse, a pulsatile nitric oxide delivery device, which is in Phase III clinical trials for the treatment of pulmonary arterial hypertension; and in Phase II clinical trials to treat pulmonary hypertension associated with chronic obstructive pulmonary diseases and pulmonary hypertension associated with idiopathic pulmonary fibrosis. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey.

Trade Information
Trade Type
LONG
ReliabilityScore™
99.60
Entry Date
Feb 10, 2017
Entry Price
0.71
Sell Date
Mar 14, 2017
Sell Price
1.48
Net Gain
108.61%
Hold Time
21 Trading Days